Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leptin, the product of the ob gene, regulates food intake, energy expenditure, and other physiological functions of the peripheral tissues. Leptin receptors have been identified in the hypothalamus and in extrahypothalamic tissues. Increased circulating
leptin
levels have been correlated with cardiovascular disease, obesity, aging, infection with bacterial
lipopolysaccharide
, and high-fat diets. All these conditions have also been correlated with increased vascular calcification, a hallmark of atherosclerotic and age-related vascular disease. In addition, the differentiation of marrow osteoprogenitor cells is regulated by
leptin
. Thus, we hypothesized that
leptin
may regulate the calcification of vascular cells. In this report, we tested the effects of
leptin
on a previously characterized subpopulation of vascular cells that undergo osteoblastic differentiation and calcification in vitro. When treated with
leptin
, these calcifying vascular cells had a significant 5- to 10-fold increase in alkaline phosphatase activity, a marker of osteogenic differentiation of osteoblastic cells. Prolonged treatment with
leptin
enhanced the calcification of these cells, further supporting the pro-osteogenic differentiation effects of
leptin
. Furthermore, the presence of the leptin receptor on calcifying vascular cells was demonstrated using reverse transcriptase polymerase chain reaction, immunocytochemistry, and Western blot analysis. We also identified the presence of leptin receptor in the mouse artery wall, localized to subpopulations of medial and adventitial cells, and the expression of
leptin
by artery wall cells and atherosclerotic lesions in mice. Taken together, these results suggest that
leptin
regulates the osteoblastic differentiation and calcification of vascular cells and that the artery wall may be an important peripheral tissue target of
leptin
action.
...
PMID:Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. 1134 6
Events in utero appear to be important factors contributing to the development of somatic disorders at adult age. The aim of this study was to examine whether maternal immune challenge would be followed at adult age by metabolic and endocrine abnormalities in the offspring. Pregnant rats were given injections of either endotoxin (Escherichia coli
lipopolysaccharide
; 0.79 mg/kg, ip) or vehicle on days 8, 10, and 12 of gestation. Adult male offspring to
lipopolysaccharide
-exposed dams were heavier than controls (P < 0.05) and showed increased adipose tissue weights (P < 0.05), elevated food intake (P < 0.05), and increased circulating
leptin
(P < 0.01). The effect of insulin on glucose uptake was reduced, as measured by an euglycemic hyperinsulinemic clamp technique (P < 0.05). Serum levels of 17beta-estradiol and progesterone were elevated (P < 0.01 and P < 0.05, respectively). Baseline levels of corticosterone were normal, but the corticosterone response to stress was attenuated (P < 0.05), and hippocampal glucocorticoid receptor protein was up-regulated (P < 0.05). Female offspring were uninfluenced, except for increased testosterone levels (P < 0.05), increased baseline corticosterone levels (P < 0.05), and enlargement of heart and adrenals (P < 0.05). The results indicate that maternal endotoxemia leads to obesity, insulin resistance, and high serum levels of
leptin
in the adult male offspring. This study reports a novel animal model of obesity with features of the metabolic syndrome.
...
PMID:Maternal endotoxemia results in obesity and insulin resistance in adult male offspring. 1135 13
Bacterial
lipopolysaccharide
(
LPS
) stimulates massive release of tumor necrosis factor-alpha (TNF-alpha) together with nitric oxide (NO) and a lessor release of
leptin
. We hypothesized that other types of stress such as that of surgery might also release these cytokines and NO. Adult male rats were anesthetized with ketamine/acepromazine/xylazine anesthesia (90 + 2 + 6 mg/ml, respectively) and an external jugular catheter was inserted for removal of blood samples (0.6 ml) at various times postoperatively. Plasma TNF-alpha was almost undetectable in decapitated rats and was near zero immediately following the placement of the jugular catheter (time zero [t0]). As the rats awakened from anesthesia, there was a rise in TNF-alpha at 30 min that peaked at 2 hr with a 400-fold increase and then precipitously declined 40-fold to a level still greater than zero at 3 hr. At 6 hr on the following morning, TNF-alpha values were near zero, but following connection of tubing and withdrawal of the initial blood sample, there was a 100-fold increase 1 hr later, followed by a decline over the next 3 hr. In contrast, plasma [NO/NO2] from decapitated rats was 117 microM. Values at tO were decreased and plummeted 4-fold within 30 min, then rose slightly in the ensuing 3 hr. At 6 hr on the next day [NO3/NO2] values were lower than at tO and declined gradually during the next 4 hr. Leptin gradually declined from pre-operative concentrations, reaching a minimum at 3 hr and its concentration was unaffected by the bleeding stress of the second day. We conclude that release of TNF-alpha, [NO3/NO2], and
leptin
are neurally controlled since plasma levels of all three declined as a result of anesthesia. TNF-alpha secretion was remarkably stress responsive, whereas NO release appeared to be suppressed by the combined operative and bleeding stress, and
leptin
was stress unresponsive.
...
PMID:Comparisons of the effects of anesthesia and stress on release of tumor necrosis factor-alpha, leptin, and nitric oxide in adult male rats. 1136 20
Fatty livers are sensitive to
lipopolysaccharide
(
LPS
) damage. This study tests the hypothesis that this vulnerability occurs because protective, antiapoptotic mechanisms are not upregulated appropriately. Genetically obese,
leptin
-deficient ob/ob mice, a model for nonalcoholic fatty liver disease, and their lean litter mates were treated with a small dose of
LPS
. General measures of liver injury, early (i.e., cytochrome c release) and late (i.e., activation of caspase 3) events that occur during hepatocyte apoptosis, and various aspects of the signal transduction pathways that induce nuclear factor-kappaB (NF-kappaB) and several of its antiapoptotic transcriptional targets (e.g., inducible nitric oxide synthase, bfl-1, and bcl-xL) were compared. Within 0.5-6 h after
LPS
exposure, cytochrome c begins to accumulate in the cytosol of normal livers, and procaspase 3 cleavage increases. Coincident with these events, kinases (e.g., AKT and Erk-1 and -2) that result in the degradation of inhibitor kappa-B are activated; NF-kappaB activity is induced, and NF-kappaB-regulated gene products accumulate. Throughout this period, there is negligible histological evidence of liver damage, and serum alanine aminotransferase values barely increase over baseline values. Although ob/ob livers have significant histological liver injury and 11-fold greater serum alanine aminotransferase values than those of lean mice by 6 h post-
LPS
, they exhibit greater activation of AKT and Erk, more profound reductions in inhibitor kappa-B, enhanced activation of NF-kappaB, and greater induction of NF-kappaB-regulated genes. Consistent with this heightened antiapoptotic response, increases in cytochrome c and procaspase 3 cleavage products are inhibited. Together with evidence that ob/ob hepatocytes have a reduced ATP content and undergo increased lysis after in vitro exposure to tumor necrosis factor-alpha, these findings suggest that fatty livers are sensitive to
LPS
damage because of vulnerability to necrosis, rather than because of apoptosis.
...
PMID:Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. 1144 19
GH treatment can increase the mortality and morbidity of critically ill patients. The mechanisms of these harmful effects of GH are unknown but have been, in part, ascribed to interactions between GH and the immune system. Because GH has pattern-dependent actions we have now compared the dose-related effects of continuous and intermittent GH treatment given with or without an endotoxin (
lipopolysaccharide
; LPS) challenge. Male Wistar rats (n=6 per group) were treated for 5 days with recombinant human GH (0, 10, 100 or 1000 microg/kg per day) using either continuous s.c. infusion by osmotic minipump or intermittent twice daily s.c. injections. On day 4, endotoxin (5 mg/kg, i.p.) was injected and the animals monitored for a further 16 h. LPS administration alone led to neutrophilia and lymphopoenia, with increased plasma concentrations of urea, cholesterol, triglyceride, insulin and
leptin
, and decreased levels of IGF-I. High dose GH infusion (1000 microg/kg per day) followed by LPS caused greater increases in plasma urea, cholesterol, triglyceride, sodium and magnesium, but lower plasma glucose and insulin levels, than treatment with LPS alone. In contrast, twice daily injections of GH did not enhance these effects of endotoxin. In conclusion, the effects of endotoxin on plasma electrolytes, lipids, urea, glucose and insulin are differentially affected by the pattern of GH administration in the rat.
...
PMID:The metabolic effects of endotoxin are differentially affected by the pattern of GH administration in the rat. 1157 1
To determine the role of
leptin
in endotoxin-induced anorexia in ruminants, circulating
leptin
levels were measured during acute experimental endotoxemia in sheep. Injection of bacterial
lipopolysaccharide
(450 ng/kg, i.v.) induced anorexia accompanied with fever and increases in serum levels of cortisol, insulin and glucose which are known to stimulate
leptin
secretion in rodent and human, while it did not affect serum
leptin
levels at all. These results indicate that serum
leptin
levels in sheep during acute endotoxemia are differentially regulated from those in rodent and human, and that
leptin
might not be involved in the endotoxin-induced anorexia in sheep.
...
PMID:No alteration in serum leptin levels during acute endotoxemia in sheep. 1171 34
Our hypothesis is that
leptin
release is controlled neurohormonally. Conscious, male rats bearing indwelling, external, jugular catheters were injected with the test drug or 0.9% NaCl (saline), and blood samples were drawn thereafter to measure plasma
leptin
. Anesthesia decreased plasma
leptin
concentrations within 10 min to a minimum at 120 min, followed by a rebound at 360 min. Administration (i.v.) of
lipopolysaccharide
(
LPS
) increased plasma
leptin
to almost twice baseline by 120 min, and it remained on a plateau for 360 min, accompanied by increased adipocyte
leptin
mRNA. Anesthesia largely blunted the
LPS
-induced
leptin
release at 120 min. Isoproterenol (beta-adrenergic agonist) failed to alter plasma
leptin
but reduced
LPS
-induced
leptin
release significantly. Propranolol (beta-receptor antagonist) produced a significant increase in plasma
leptin
but had no effect on the response to
LPS
. Phentolamine (alpha-adrenergic receptor blocker) not only increased plasma
leptin
(P < 0.001), but also augmented the
LPS
-induced increase (P < 0.001). alpha-Bromoergocryptine (dopaminergic-2 receptor agonist) decreased plasma
leptin
(P < 0.01) and blunted the
LPS
-induced rise in plasma
leptin
release (P < 0.001). We conclude that
leptin
is at least in part controlled neurally because anesthesia decreased plasma
leptin
and blocked its response to
LPS
. The findings that phentolamine and propranolol increased plasma
leptin
concentrations suggest that
leptin
release is inhibited by the sympathetic nervous system mediated principally by alpha-adrenergic receptors because phentolamine, but not propranolol, augmented the response to
LPS
. Because alpha-bromoergocryptine decreased basal and
LPS
-induced
leptin
release, dopaminergic neurons may inhibit basal and
LPS
-induced
leptin
release by suppression of release of prolactin from the adenohypophysis.
...
PMID:Lipopolysaccharide-induced leptin release is neurally controlled. 1172 49
Lipopolysaccharides (LPS) are major components of the outer membrane of gram-negative bacteria playing a central role as potent endotoxins in the pathogenesis of endotoxic shock. Although large amounts of endotoxin may produce hemorrhagic lesions in the stomach, the possible gastroprotective effect of central or peripheral LPS against the acute gastric lesions has not been extensively studied. The aim of the present study was to compare the effect of intracerebroventricular (i.c.v.) and parenteral (i.p.) injection of LPS against gastric lesions induced by 100% ethanol. Male Wistar rats were treated either with a) vehicle (control); b) E-coli-LPS in various concentrations (1-10 microg/kg i.c.v or 0.1-40 mg/kg i.p.) followed 30 min later by 100% ethanol. The effects of pretreatment with nonselective inhibitor of nitric oxide synthase (L-NAME, 20 mg/kg i.g.) or selective inhibitor of inducible nitric oxide synthase, L-NIL (30 mg/kg i.g.) on the gastroprotection induced by LPS was investigated. One hour after ethanol application, the gastric blood flow (GBF) and the area of gastric lesions were determined. In addition, the mucosal expression of iNOS, cNOS and
leptin
was assessed using RT-PCR. LPS applied i.c.v. or i.p. dose dependently reduced gastric lesions induced by ethanol and this effect was similar to that observed after the administration of NO donor (SNAP). LPS-induced protection was significantly abolished by L-NAME and significantly attenuated by the selective inhibitor of iNOS (L-NIL). The expression of cNOS was detected in vehicle treated gastric mucosa and did not change after LPS administration. iNOS was not detectable in intact mucosa but its expression dose-dependently increased after the LPS administration. The i.c.v. administration of LPS did not upregulate further the iNOS expression, and dose-dependently inhibited the
leptin
mRNA expression in gastric mucosa. We conclude that LPS applied centrally or peripherally protects gastric mucosa against ethanol-induced damage through an increase in gastric microcirculation mediated by NO due to overexpression of iNOS. Transcriptional downregulation of
leptin
in gastric mucosa is probably due to the increased
leptin
release induced by the intracerebroventricular application
lipopolysaccharide
.
...
PMID:Central and peripheral neural aspects of gastroprotective and ulcer healing effects of lipopolysaccharides. 1178 62
Anorexia and weight loss are frequent complications of acute and chronic infections and result from induction of cytokines, prostaglandins, and other inflammatory mediators that are critical for pathogen elimination. Selective attenuation of the hypophagic response to infection and maintenance of the production of factors essential for infection control would be a useful addition to antimicrobial therapy in the treatment of human disease. Here, we evaluate the relative contribution of cyclooxygenase (COX)-1- and COX-2-derived prostaglandins to anorexia and weight loss precipitated by systemic immune activation by
lipopolysaccharide
(
LPS
). Using COX isoform-selective pharmacological inhibitors and gene knockout mice, we found that COX-2 inhibition during
LPS
-induced inflammation results in preserved food intake and maintenance of body weight, whereas COX-1 inhibition results in augmented and prolonged weight loss. Regulation of neuropeptide Y, corticotropin-releasing hormone,
leptin
, and interleukin-6 does not change as a function of COX-2 inhibition after
LPS
administration. Our data implicate COX-2 inhibition as a therapeutic target to maintain nutritional status while still allowing a normal cytokine response during infection.
...
PMID:COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. 1183 69
Type 2 diabetes is associated with biochemical evidence of low-grade inflammation, and experimental studies have suggested that both insulin and glucose affect inflammatory responses. To determine the effect of in vivo changes in glucose availability and plasma insulin concentrations in humans, we administered 20 U/kg Escherichia coli
lipopolysaccharide
(
LPS
) or saline (control) to 14 subjects during a euglycemic hyperinsulinemic clamp (n = 6) or an infusion of sterile saline (n = 8). Parallel in vitro studies on human whole blood were undertaken to determine whether there was a direct effect of glucose, insulin, and
leptin
on proinflammatory cytokine production. Infusion of glucose and insulin significantly amplified and/or prolonged the cardiovascular, plasma interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and counterregulatory hormone responses to
LPS
, whereas the effects on fever, plasma norepinephrine concentrations, and oxygen consumption were unaffected. In vitro studies showed no modulation of
LPS
-stimulated IL-6 or TNF-alpha production by glucose, insulin, or
leptin
at physiologically relevant concentrations. Hyperinsulinemia indirectly enhances key components of the systemic inflammatory and stress responses in this human model of infection.
...
PMID:Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. 1200 57
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>